Wanbury
WANBURY •NSE

Wanbury

₹192.410.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Livesquawk •
Wanbury reported Q2 EBITDA of ₹260M, up slightly from ₹257.8M YoY. Q2 EBITDA margin contracted to 14.3% compared to 16.2% YoY.
Livesquawk •
Wanbury received the Australian TGA GMP compliance certificate for its Tanuku manufacturing facility. The certification strengthens the company's standing and standards in global pharmaceutical manufacturing.
Livesquawk •
Wanbury received 9 'No DMF deficiency' letters from the USFDA for its Metformin HCL submissions. The company is expanding its Metformin business in Saudi Arabia and Mexico.
Livesquawk •
Wanbury launched its BerrySoft Baby product line across several Indian states, expanding into the pediatric dermatology segment. The company secured GST registrations across five states and obtained CF drug licenses in multiple areas.